Bronstein, Gewirtz & Grossman, LLC: Investigating Alleged Securities Law Violations at Inari Medical

Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Inari Medical, Inc. New York, NY – In a recent press release, Bronstein, Gewirtz & Grossman, LLC, a prominent securities litigation firm, announced that it is investigating potential claims on behalf of investors of Inari Medical, Inc. (Inari or the Company) (NASDAQ: NARI). The investigation comes…

Read More

Jasper Therapeutics Releases Q4 and Full Year 2024 Financial Results, Offers Corporate Update

Jasper Therapeutics Reports Q4 and Full Year 2024 Results, Provides Corporate Update Redwood City, California-based Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company specializing in the development of briquilimab, an innovative antibody therapy, announced financial results for the fourth quarter and full year ended December 31, 2024. The company also provided an update on…

Read More

“Uncovering the Truth: Why Freeport-McMoRan is Still Overvalued After Earnings Report”

Freeport-McMoRan Inc.’s Earnings and Outlook Continued Execution and Balance Sheet Strength Freeport-McMoRan Inc., a leading mining company, recently reported its earnings which showcased continued execution and a reasonably strong balance sheet. Despite the challenges posed by the global economic landscape, the company has managed to maintain its profitability and financial stability. Production Projections Looking ahead,…

Read More